Evidence map›Paper›PMID 39911955›Full record

ArticleJournal of lipid and atherosclerosis2025

Association Between Lipoprotein (a) Levels and Coronary Artery Disease (CAD) Among Patients With or Without CAD Family History.

Hayato Tada, Nobuko Kojima, Kan Yamagami, Yasuaki Takeji, Kenji Sakata, Soichiro Usui, Masa-Aki Kawashiri, Masayuki Takamura

Abstract read
In one paragraph

Article in Journal of lipid and atherosclerosis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. It's Time to Measure Lp(a): Recognizing a Neglected Cardiovascular Risk.Journal of atherosclerosis and thrombosis · 2026
    Article
  2. Article
  3. Does Lp(a) Help to Identify High-risk Plaques?Journal of atherosclerosis and thrombosis · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hayato TadaDepartment of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.ORCID https://orcid.org/0000-0002-3357-1809
Nobuko KojimaDepartment of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
Kan YamagamiDepartment of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
Yasuaki TakejiDepartment of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
Kenji SakataDepartment of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.ORCID https://orcid.org/0000-0002-6312-8912
Soichiro UsuiDepartment of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.ORCID https://orcid.org/0000-0003-1752-8082
Masa-Aki KawashiriDepartment of Internal Medicine, Kaga Medical Center, Kaga, Japan.ORCID https://orcid.org/0000-0002-5759-1353
Masayuki TakamuraDepartment of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.ORCID https://orcid.org/0000-0002-1540-4417

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Lipoprotein (a) (Lp[a]), which is a highly heritable trait, is associated with coronary artery disease (CAD). However, the insight into whether the association between Lp(a) and CAD differs according to the family history of CAD remains unclear. Methods: We investigated clinical data of 4,512 participants who underwent serum Lp(a) level measurement at Kanazawa University Hospital between 2008 and 2016. The association between Lp(a) and CAD according to CAD family history was investigated through logistic regression analyses. Results: CAD family history and Lp(a) levels were significantly associated with CAD development (odds ratio [OR], 1.32; 95% confidence interval [CI], 1.12-1.52; Conclusion: Lp(a) level was associated with CAD development regardless of CAD family history status.

Indexed as

Coronary artery diseaseLipoproteinLipoprotein(a)Medical family history

Identifiers

PMID39911955
PMCPMC11791416

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.